Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors-Reference-Cited by-同舟云学术

Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors

Published:2019-08-11 Issue:1 Volume:38 Page:160-171
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Refae Sadal,Gal Jocelyn,Ebran Nathalie,Otto Josiane,Borchiellini Delphine,Peyrade Frederic,Chamorey Emmanuel,Brest Patrick,Milano Gérard,Saada-Bouzid Esma

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-019-00845-w.pdf

Reference50 articles.

1. Ribas A, Wolchok JD (2018) Cancer immunotherapy using checkpoint blockade. Science 359(6382):1350–1355

2. Sharma P, Allison JP (2015) The future of immune checkpoint therapy. Science 348(6230):56–61

3. Havel JJ, Chowell D, Chan TA (2019) The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy. Nat Rev Cancer 19(3):133–150

4. Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M, Schuster SJ, Millenson MM, Cattry D, Freeman GJ, Rodig SJ, Chapuy B, Ligon AH, Zhu L, Grosso JF, Kim SY, Timmerman JM, Shipp MA, Armand P (2015) PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma. N Engl J Med 372(4):311–319

5. Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L, Carcereny E, Ahn MJ, Felip E, Lee JS, Hellmann MD, Hamid O, Goldman JW, Soria JC, Dolled-Filhart M, Rutledge RZ, Zhang J, Lunceford JK, Rangwala R, Lubiniecki GM, Roach C, Emancipator K, Gandhi L (2015) Pembrolizumab for the treatment of non-small-cell lung cancer. N Engl J Med 372(21):2018–2028

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential prognostic predictors of treatment with immune checkpoint inhibitors for advanced endometrial cancer;Japanese Journal of Clinical Oncology;2024-09-03

2. The association between single-nucleotide polymorphisms within type 1 interferon pathway genes and human immunodeficiency virus type 1 viral load in antiretroviral-naïve participants;AIDS Research and Therapy;2024-05-03

3. Immunotherapy for colorectal cancer: insight from inherited genetics;Trends in Cancer;2024-05

4. The Current and Future of Biomarkers of Immune Related Adverse Events;Rheumatic Disease Clinics of North America;2024-05

5. Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors: Position statement of the AEEH–AEG–SEPD–SEOM–GETECCU;Gastroenterología y Hepatología;2024-04